Midazolam and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Midazolam (midazolam) and Cymbalta (duloxetine hydrochloride). Common drug interactions include allodynia among females and drug intolerance among males.

The phase IV clinical study analyzes what interactions people have when they take Midazolam and Cymbalta. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,974 Cymbalta users. Check the latest studies of Cymbalta.



On Aug, 06, 2026

47 people who take Midazolam and Cymbalta together, and have interactions are studied.

Midazolam and Cymbalta drug interactions.

What are the common drug interactions of Midazolam and Cymbalta, by gender? *:

female:

  1. Allodynia (a condition in which pain is caused by a stimulus that does not normally elicit pain)
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Bone density decreased
  4. Cellulitis (infection under the skin)
  5. Colitis ulcerative (inflammation of colon with ulcer)
  6. Death
  7. Fall
  8. Gastric cancer stage iv (cancer cells have spread to distant organs)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Haematochezia (passage of stools containing blood)

male:

  1. Drug intolerance (drug sensitivity)
  2. Pancreatitis (inflammation of pancreas)
  3. Anion gap increased
  4. Asthenia (weakness)
  5. Back disorder
  6. Back pain
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Catheter site pain
  9. Constipation
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Midazolam and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Allodynia (a condition in which pain is caused by a stimulus that does not normally elicit pain)
  2. Hyperaesthesia

30-39:

  1. Urinary tract infection
  2. Viral upper respiratory tract infection
  3. Weight decreased
  4. Bone density decreased
  5. Brain death
  6. Cardiomegaly (increased size of heart than normal)
  7. Colitis ulcerative (inflammation of colon with ulcer)
  8. Haematochezia (passage of stools containing blood)
  9. Hepatic failure (liver failure)
  10. Nasopharyngitis (inflammation of the nasopharynx)

40-49:

  1. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Abscess limb (limb infection)
  4. Chronic kidney disease
  5. Nerve injury
  6. Pain
  7. Perirectal abscess
  8. Rectal abscess (pus in rectum)
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

50-59:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Iga nephropathy (kidney disease- condition prevents the kidneys from filtering waste)
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Nephrogenic anaemia (anaemia due to kidney disease)
  9. Proteinuria (presence of protein in the urine)
  10. Renal tubular necrosis (death of kidney tubules)

60+:

  1. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  2. Prostate cancer
  3. Hypokalaemia (low potassium)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Intervertebral disc degeneration (spinal disc degeneration)
  6. Laryngeal cancer (cancer of the larynx)
  7. Obesity (having too much body fat)
  8. Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)
  9. Perineal abscess
  10. Pituitary-dependent cushing's syndrome (pituitary dependent hypercortisolism)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 31.91%
  2. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 15 people, 31.91%
  3. Type 2 Diabetes: 12 people, 25.53%
  4. Pain: 12 people, 25.53%
  5. High Blood Pressure: 9 people, 19.15%
  6. Diabetes: 9 people, 19.15%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 14.89%
  8. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery): 7 people, 14.89%
  9. Gastric Ulcer (stomach ulcer): 7 people, 14.89%
  10. Diarrhea: 7 people, 14.89%

* Approximation only. Some reports may have incomplete information.

Do you take Midazolam and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Midazolam and Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cymbalta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on midazolam and duloxetine hydrochloride (the active ingredients of Midazolam and Cymbalta, respectively), and Midazolam and Cymbalta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: